Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA)

Inflammation Research

Volumn 53, Issue 5, 2004, Pages 189-198

  Rontzsch A ^a   Thoss, K ^a   Petrow, P K ^a   Henzgen, S ^b   Brauer R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Androstenediol, Cell mediated immunity; Antigen induced arthritis; Autoantibodies; Dehydroepiandrosterone; Th1 Th2 balance

Indexed keywords

PRASTERONE;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOLOGY; INFLAMMATION; MALE; METHYLATION; MOUSE; NONHUMAN; SEX RATIO; TUBERCULOUS ARTHRITIS;

ADJUVANTS, IMMUNOLOGIC; ANDROSTENEDIOL; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE I; COLLAGEN TYPE II; DEHYDROEPIANDROSTERONE; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; PROTEOGLYCANS; SERUM ALBUMIN, BOVINE; SEVERITY OF ILLNESS INDEX;

EID: 2442555998     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00011-003-1244-y     Document Type: Article

References (47)

1. Cutolo M, Straub RH. Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis. Ann Rheum Dis 2000; 59: 657-61.
2. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis. Arthritis Rheum 2001; 44: 493-507.
3. Regelson W, Loria R, Kalimi M. Dehydroepiandrosterone (DHEA) - the 'mother steroid'. I. Immunologic action. Ann New York Acad Sci 1994; 719: 553-63.
4. Wilder RL. Adrenal and gonadal steroid hormone deficiency in the etiopathogenesis of rheumatoid arthritis. J Rheumatol 1996; 44 suppl: 10-2.
5. McKenna TJ, Fearon U, Clarke D, Cunningham SK. A critical review of the origin and control of adrenal androgens. Bailliere's Clin Obstet Gynaecol 1997; 11: 229-48.
6. Svec F, Porter JR. The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med 1998; 218: 174-91.
7. Blauer KL, Poth M, Rogers WM, Bernton EW. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 1991; 129: 3174-9.
8. Punjabi U, Deslypere JP, Verdonck L, Vermeulen A. Androgen and precursor levels in serum and testes of adult rats under basal conditions and after hCG stimulation. J Steroid Biochem 1983; 19: 1481-90.
9. Hung TT, LeMaire WJ. The effects of corticotropin, opioid peptides and crude pituitary extract on the production of dehydroepiandrosterone and corticosterone by mature rat adrenal cells in tissue culture. J Steroid Biochem Mol Biol 1988; 29: 721-6.
10. Kalimi M, Shafagoj Y, Loria R, Padgett D, Regelson W. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem 1994; 131: 99-104.
11. Suzuki T, Suzuki N, Daynes RA, Engleman EG. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol Immunopathol 1991; 61: 202-11.
12. Du C, Khali MW, Sriram S. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J Immunol 2001; 167: 7094-101.
13. Loria RM, Padgett DA, Huynh PN. Regulation of the immune response by dehydroepiandrosterone and ist metabolites. J Endocrinol 1996; 150 suppl: 209-20.
14. Loria RM, Padgett DA. Androstenediol regulates systemic resistance against lethal infections in mice. Arch Virol 1992; 127: 103-15.
15. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY et al. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993; 150: 5219-30.
16. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: Possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83: 2012-17.
17. Spencer NFL, Norton SD, Harrison LL, Li GZ, Daynes RA. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp Gerontol 1996; 31: 393-408.
18. Du C, Guan Q, Khalil MW, Sriram S. Stimulation of Th2 response by high doses of dehydroepiandrosterone in KLH-primed splenocytes. Exp Biol Med 2001; 226: 1051-60.
19. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL et al. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol 1992; 42: 293-304.
20. Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH. Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 2000; 164: 161-9.
21. Hedmann M, Nilsson E, De La Torre B. Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus. Clin Exp Rheumatol 1989; 7: 583-8.
22. Cutolo M, Sulli A, Villaggio B, Seriolo B, Accardo S. Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1998; 57: 573-7.
23. Masi AT. Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? Clin Exp Rheumatol 1995; 13: 227-40.
24. Dessein PH, Joffe BI, Stanwix AE, Moomal Z. Hyposecretion of the adrenal androgen dehydroepiandrosterone sulfate and its relation to clinical variables in inflammatory arthritis. Arthritis Res 2001; 3: 183-8.
25. Khalkhali-Ellis Z, Moore TL, Hendrix MJC. Reduced levels of testosterone and dehydroepiandrosterone sulphate in the serum and synovial fluid of juvenile rheumatoid arthritis patients correlates with disease severity. Clin Exp Rheumatol 1998; 16: 753-6.
26. Masi AT, Chatterton AT, Comstock GW, Malamet RL, Hochberg MC. Decreased serum dehydroepiandrosterone sulfate (DHAS) levels before onset of RA in younger, premenopausal women: a controlled, prospective study. Arthritis Rheum 1994; 37: S315.
27. Heikkilä R, Aho K, Heliövaara M, Knekt P, Reunanen A, Aromaa A et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998; 57: 281-5.
28. Williams PJ, Jones RHV, Rademacher TW. Reduction in the incidence and severity of collagen-induced arthritis in DBA/1 mice, using exogenous dehydroepiandrosterone. Arthritis Rheum 1997; 40: 907-11.
29. Giltay EJ, van Schaardenburg D, Gooren LJG, von Bloomberg BME, Fonk JCM, Touw DJ et al. Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis. Br J Rheumatol 1998; 37: 705-6.
30. van Vollenhoven RF, Morabito LM, Engleman EG, McGuire JL. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998; 25: 285-9.
31. Austrup F, Vestweber D, Borges E, Löhning M, Bräuer R, Herz U et al. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997; 385: 81-3.
32. Crossley MJ, Holland T, Spowage M, Hunneyball IM. Monoarticular antigen-induced arthritis in rabbits and mice. In: Pharmacological Methods in the Control of Inflammation (Chung et al., eds), vol 5: 415-39, Alan R Liss Inc, 1989.
33. Simon J, Surber R, Kleinstäuber G, Petrow PK, Henzgen S, Kinne RW et al. Systemic macrophage activation in locally-induced experimental arthritis. J Autoimmun 2001; 17: 127-36.
34. Farmer LM, Watt G, Glatt M, Blaettler A, Loutis N, Feige U. Delayed-type hyersensitivity (DTH) to type II collagen (CII) in DBA-1 mice. Clin Exp Immunol 1986; 65: 329-35.
35. Bräuer R, Kittlick PD, Thoss K, Henzgen S. Different immunological mechanisms contribute to cartilage destruction in antigen-induced arthritis. Exp Toxicol Pathol 1994; 46: 383-8.
36. Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS et al. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303-33.
37. Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26: 282-8.
38. Dunn CJ, Galinet LA, Gibbons AJ, Shields SK. Murine delayed-type hypersensitivity granuloma: an improved model for the identification and evaluation of different classes of anti-arthritic drugs. Int J Immunopharmacol 1990; 12: 899-904.
39. Hambleton P, McMahon S. Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritis. Agents Actions 1990; 29: 328-32.
40. 't Hart BA, Kraakman E, Jonker M. An ear swelling reaction for in vivo monitoring of inflammatory T cell activity in collagen-arthritic rats. J Immunol Meth 1994; 176: 179-84.
41. Miossec P. Acting on the cytokine balance to control autoimmunity and chronic inflammation. Eur Cytokine Netw 1993; 4: 245-51.
42. van Vollenhoven RF, McGuire JL. Estrogen, progesterone, and testosterone: can they be used to treat autoimmune diseases? Cleveland Clin J Med 1994; 61: 276-84.
43. Steward A, Bayley DL. Effects of androgens in models of rheumatoid arthritis. Agents Actions 1992; 35: 268-72.
44. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 1991; 34: 1-5.
45. Cutolo M, Accardo S, Villaggio B, Clerico P, Indiveri F, Carruba G et al. Evidence for the presence of androgen receptors in the synovial tissue of rheumatoid arthritis patients and healthy controls. Arthritis Rheum 1992; 35: 1007-15.
46. Hennebold JD, Daynes RA. Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines. Endocrinology 1994; 135: 67-75.
47. Rau E, Boshell T, Martin L, DeBoisblanc B, Svec F, Porter JR. DHEA effect on mortality caused by experimental sepsis in lean and obese Zucker rats. J Invest Med 1995; 43: 46A.